PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'RPM Bioinfo Solutions, Blainville, Quebec, Canada.\', \'Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.\', \'Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: jeffrey.alan.tomalka@emory.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1879-6257(21)00152-810.1016/j.coviro.2021.11.012
?:doi
?:hasPublicationType
?:journal
  • Current opinion in virology
is ?:pmid of
?:pmid
?:pmid
  • 34902803
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.69
?:rankingScore_hIndex
  • 50
is ?:relation_isRelatedTo_publication of
?:title
  • Translating known drivers of COVID-19 disease severity to design better SARS-CoV-2 vaccines.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34902803>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34902803>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all